Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tambrands

This article was originally published in The Gray Sheet

Executive Summary

Chairman and CEO Martin Emmett, 58, resigns effective June 1. The White Plains, New York maker of Tampax tampons appointed Howard Wentz, Jr., 63, to replace him as chairman and is commencing a search for a new CEO. Wentz has been a director since 1985. The firm announced in a June 2 press release that it expects second quarter earnings to be "significantly below" year- ago period earnings of $0.72 a share, "due largely to reduction and liquidation of trade customers' inventory, increased marketing expenditures, and competitive pressures." The firm is also predicting 1993 earnings below the 1992 level of $3.06 per share.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel